Valuation (57%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 21.24 | 22.52 |
PEG Ratio (TTM) | 9.43 | -15.54 |
P/S Ratio (TTM) | 5.79 | 4.96 |
P/B Ratio (TTM) | 8,499.59 | 4.21 |
P/FCF Ratio (TTM) | 25.46 | 2.91 |
Price to 5YR AVG Earnings Ratio | 24.17 | 25.67 |
Price to 5YR AVG FCF Ratio | 27.08 | 27.69 |
Profitability (85%) |
Company | Industry |
---|---|---|
ROA (TTM) | 9,822.41% | 2,867.73% |
ROE (TTM) | 56.54% | 30.01% |
Net Profit Margin (TTM) | 27.33% | 24.62% |
ROIC 5YR AVG | 17.17% | 14.42% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 2.37% | -16.76% | 45.04% |
Revenue | 0.65% | -23.21% | 44.82% |
Net Income | 2.32% | -19.85% | 42.59% |
Cash Flow | 7.51% | -30.20% | 44,933,965.06% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.37 | 0.92 |
Quick Ratio (TTM) | 1,230.85 | 0.87 |
D/E Ratio (TTM) | 56.48 | 17.18 |
Interest Coverage (TTM) | 9.07 | 8.74 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | N/A | 2.42 |
LTL to 5YR AVG FCF | 6.24 | 6.44 |
Shares Outstanding Growth 5YR AVG | -2.83% | -0.35% |